Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学NK/T-Cell Lymphoma, PD-1 Inhibition

Yok-Lam Kwong

MD, FRCP, FRCPath

🏢The University of Hong Kong / Queen Mary Hospital🌐Hong Kong

Professor of Medicine, Clinical Oncology

60
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Yok-Lam Kwong is a preeminent Hong Kong hematologist with long-standing expertise in NK/T-cell lymphoma who has contributed foundational work on EBV biology, asparaginase regimens, and more recently the rationale and clinical evidence for PD-1/PD-L1 checkpoint inhibition in EBV-driven NK/T-cell lymphoma. He established that EBV-driven LMP1 upregulates PD-L1, providing mechanistic rationale for checkpoint blockade in this disease.

Share:

🧪Research Fields 研究领域

pembrolizumab NK/T-cell lymphoma
PD-L1 expression NK/T-cell
EBV LMP1 PD-L1
immunotherapy EBV lymphoma
Hong Kong lymphoma experience

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Yok-Lam Kwong 的研究动态

Follow Yok-Lam Kwong's research updates

留下邮箱,当我们发布与 Yok-Lam Kwong(The University of Hong Kong / Queen Mary Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment